RU2011135741A - Лечение псориаза - Google Patents

Лечение псориаза Download PDF

Info

Publication number
RU2011135741A
RU2011135741A RU2011135741/15A RU2011135741A RU2011135741A RU 2011135741 A RU2011135741 A RU 2011135741A RU 2011135741/15 A RU2011135741/15 A RU 2011135741/15A RU 2011135741 A RU2011135741 A RU 2011135741A RU 2011135741 A RU2011135741 A RU 2011135741A
Authority
RU
Russia
Prior art keywords
composition
nitric oxide
aqueous composition
psoriasis
composition according
Prior art date
Application number
RU2011135741/15A
Other languages
English (en)
Russian (ru)
Inventor
Пол Дэвис
Эндрю ОСТИН
Ян ЕЗЕК
Original Assignee
Инсенс Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Инсенс Лимитед filed Critical Инсенс Лимитед
Publication of RU2011135741A publication Critical patent/RU2011135741A/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/02Adhesive bandages or dressings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/095Sulfur, selenium, or tellurium compounds, e.g. thiols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007Drug-containing films, membranes or sheets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
RU2011135741/15A 2009-01-29 2010-01-22 Лечение псориаза RU2011135741A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0901456.4A GB0901456D0 (en) 2009-01-29 2009-01-29 Treatment of psoriasis
GB0901456.4 2009-01-29
PCT/GB2010/050091 WO2010086637A1 (en) 2009-01-29 2010-01-22 Treatment of psoriasis

Publications (1)

Publication Number Publication Date
RU2011135741A true RU2011135741A (ru) 2013-03-10

Family

ID=40469254

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2011135741/15A RU2011135741A (ru) 2009-01-29 2010-01-22 Лечение псориаза

Country Status (11)

Country Link
US (1) US20110287113A1 (enExample)
EP (1) EP2391356A1 (enExample)
JP (1) JP2012516315A (enExample)
KR (1) KR20110120287A (enExample)
CN (1) CN102369004A (enExample)
AU (1) AU2010209455A1 (enExample)
BR (1) BRPI1007543A2 (enExample)
CA (1) CA2750758A1 (enExample)
GB (1) GB0901456D0 (enExample)
RU (1) RU2011135741A (enExample)
WO (1) WO2010086637A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2678069A4 (en) * 2011-02-25 2015-03-25 Univ Windsor DEVICE FOR CONTROLLED RELEASE OF TOPICAL STAIN OXIDE
JP6608382B2 (ja) * 2014-02-26 2019-11-20 ルマ セラピューティクス,インク. 紫外光治療装置及び方法
ITUB20154719A1 (it) 2015-10-21 2017-04-21 Glano Tech Ltd Formulazione per il rilascio di ossido nitrico
CN109310527A (zh) 2016-02-09 2019-02-05 鲁玛治疗公司 用于通过光疗法来治疗牛皮癣的方法、组合物和设备
US10716805B2 (en) * 2018-03-19 2020-07-21 Glanotech Limited Formulation for release of nitric oxide
GB2588748A (en) * 2019-10-07 2021-05-12 Insense Ltd Composition for delivering nitric oxide to skin
BR112022005166A2 (pt) * 2019-10-07 2022-06-14 Insense Ltd Composição de aplicação à pele
KR102333779B1 (ko) * 2020-02-03 2021-12-03 주식회사 큐라젠 산화질소 플라즈마를 이용한 돌출형 폴리우레탄 드레싱폼 및 그 제조 방법

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4305881C1 (de) * 1993-02-26 1994-03-03 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit Wirkstoffen, welche Stichoxid-Quellen darstellen, Verfahren zu seiner Herstellung sowie seine Verwendung
US7052711B2 (en) * 1999-09-02 2006-05-30 Rice University Nitric oxide-producing hydrogel materials
US20030147835A1 (en) 2000-06-15 2003-08-07 Munro Hugh Semple Process for the manufacture of hydrogel compositions and hydrogel compositions manufactured thereby
GB0021317D0 (en) * 2000-08-30 2000-10-18 Queen Mary & Westfield College Transdermal pharmaceutical delivery composition
EP1693073B1 (en) 2002-04-24 2014-07-23 Archimed LLP Wound dressings comprising hydrated hydrogels and enzymes
US20040062793A1 (en) * 2002-07-05 2004-04-01 Dyke Mark Van Tissue defect dressings comprising proteinaceous networks
US20070059351A1 (en) * 2003-10-17 2007-03-15 Murrell George A C Transdermal patches containing a nitric oxide-donor and a second active agent and associated methods
MX2007009691A (es) * 2005-02-11 2008-02-12 Nolabs Ab Dispositivo y metodo para el tratamiento de dermatomicosis y, en particular, de onicomicosis.
EP1690558A1 (en) * 2005-02-11 2006-08-16 NOLabs AB Device for treatment of diabetic disorders
EP1846009A2 (en) * 2005-02-11 2007-10-24 NOLabs AB Improved device for application of medicaments, manufacturing method therefor, and method of treatment
GB0505035D0 (en) * 2005-03-11 2005-04-20 Insense Ltd Improvements relating to skin dressings
EP1704876A1 (en) * 2005-03-24 2006-09-27 NOLabs AB Cosmetic treatment, device for performing said treatment and manufacturing method thereof
GB0616350D0 (en) * 2006-08-17 2006-09-27 Univ St Andrews Adsorption and release of nitric oxide in metal organic frameworks
US20080206364A1 (en) * 2006-10-13 2008-08-28 Nitric Biotherapeutics, Inc. Topical nitric oxide as a treatment of autoimmune diseases
GB0715554D0 (en) 2007-08-09 2007-09-19 Insense Ltd Improvements relating to skin dressings

Also Published As

Publication number Publication date
EP2391356A1 (en) 2011-12-07
US20110287113A1 (en) 2011-11-24
WO2010086637A1 (en) 2010-08-05
KR20110120287A (ko) 2011-11-03
CN102369004A (zh) 2012-03-07
JP2012516315A (ja) 2012-07-19
GB0901456D0 (en) 2009-03-11
BRPI1007543A2 (pt) 2016-02-16
CA2750758A1 (en) 2010-08-05
AU2010209455A1 (en) 2011-08-18

Similar Documents

Publication Publication Date Title
RU2011135741A (ru) Лечение псориаза
JP2012516315A5 (enExample)
ATE495767T1 (de) Regelungsverfahren für die eluierung von therapeutischen wirkstoffen
CL2008003088A1 (es) Metodo de preparacion de la sal de de maleato de (e)-n-{4-[3-cloro-4-(2-piridinilmetoxi)anilino]-3-ciano-7-etoxi-6-quinolinil}-4-(dimetilanino)-2-butenamida; formas cristalinas anhidra y monohidrato de la sal maleato; metodo de preparacion; composicion farmaceutica; utiles en el tratamiento de cancer.
WO2009134967A3 (en) Use of nucleic acids with reduced pressure therapy for treating wounds
ATE539721T1 (de) Vorrichtung zur wundbehandlung
AR095855A1 (es) Método de tratamiento de un sustrato animal
MX365380B (es) Formulacion de hidrogel que comprende agua con ppotencial de oxidacion-reduccion.
DE602004017720D1 (de) Bausatz, vorrichtung und verfahren zur gesteuerten abgabe eines oxidationsmittels in die haut
BRPI0714251A2 (pt) "curativo sólido para tratar tecido com ferimento,método para tratar um tecido com ferimento e composição de curativo sólido"
DE602005026724D1 (de) Verfahren zur verwendung von aus fettgewebe stammenden zellen bei der behandlung von herz-kreislauf-leiden
EP2133044A3 (de) Wirkstoffbeladenes Implantat
EP4249431A3 (en) Compositions and methods for treating diseases or disorders using extended release nitric oxide releasing solutions
WO2010031777A3 (en) Device and method for regenerative therapy by high intensity laser therapy
UY30158A1 (es) Uso de derivados de benzo-heteroaril sulfamida para el tratamiento del dolor
RU2014150505A (ru) Способ идентификации лигандов рецептора ahr, которые обладают терапевтической себосупрессивной активностью, и указанные лиганды
MX2015011283A (es) Composicion inyectable de colageno polimerizable in situ.
ATE501247T1 (de) Verfahren zur verwendung regenerativer zellen zur förderung der wundheilung
AR044315A1 (es) Agente para prevenir y/o tratar enfermedades acompañadas de alteraciones de tejidos que comprende un polipeptido
ATE553760T1 (de) Verwendung von alverin zur behandlung von hauterkrankungen
EP1844779A3 (de) Tergurid/Protergurid zur Behandlung von chronischen Schmerzen (z.B. Migräne)
MX2019003751A (es) Proteina terapeutica.
BR112014012966A2 (pt) método para o controle da proliferação de pseudomonas; e uso de um agente de desinfecção
MX2023013070A (es) Formulaciones liquidas ionicas para el tratamiento de enfermedades inflamatorias y autoinmunes.
WO2019099860A3 (en) Wound treatment containing collagen and a gelatin-reducing agent, and method for promoting wound healing

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20141118